Chronic inflammation is a critical residual risk for the transition from health to cardiovascular disease (CVD) but with limited opportunities to stop without immunosuppression. The goal is to identify the resolution of inflammation and develop new preventive strategies against the chronic inflammation that drives CVD. An individual's critical immune pathways will be identified and validated with machine learning to provide new tools for a personalized plan towards resolution of inflammation.